まとめ
血液凝固第XII因子(FXII)欠乏症は、偶発的に発見されることが多い稀な疾患です。この症例は、出血症状がないにもかかわらず活性化部分トロンボプラスチン時間(APTT)が延長している患者において、FXII欠乏症を考慮することの重要性を強調しています。
科学分野:
- 血液学
- 臨床病理学
背景:
- 血液凝固第XII因子(FXII)欠乏症は、稀な遺伝性出血性疾患です。
- 特異的な症状がないため、日常的なスクリーニング中に偶発的に診断されることが多いです。
研究 の 目的:
- FXII欠乏症の症例を報告すること。
- 出血症状のない患者における活性化部分トロンボプラスチン時間(APTT)延長の原因を調査すること。
主な方法:
- 活性化部分トロンボプラスチン時間(APTT)混合試験を実施しました。
- 特異的凝固因子アッセイを実施しました。
- 抗リン脂質抗体およびループスアンチコアグラントの検査を実施しました。
主要な成果:
- 患者は、臨床的な出血症状がないにもかかわらず、著しく延長したAPTTを呈しました。
- 凝固因子アッセイにより、FXII活性が著しく低下している(0.1%)ことが確認されました。
- 混合試験および特異的抗体試験により、APTT延長の他の原因が除外されました。
結論:
- 無症候性の個人におけるAPTTの延長は、FXII欠乏症を示唆する可能性があります。
- 検査担当者は、説明のつかないAPTT延長の結果に対してFXII欠乏症を考慮する必要があります。
関連する概念動画
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K
Coagulation
9.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.7K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280


